TIPE2	B:C2975187
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	O
in	O
Prostate	O
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	B:C1514559
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	O
in	O
Prostate	O
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	B:C1533574
,	O
and	O
Invasion	O
in	O
Prostate	O
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	B:C1269955
in	O
Prostate	O
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	O
in	O
Prostate	B:C0376358
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	O
in	O
Prostate	O
Cancer	I:C0376358
Cells	B:C0334227
by	O
Inhibiting	O
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

TIPE2	O
Overexpression	O
Suppresses	O
the	O
Proliferation	O
,	O
Migration	O
,	O
and	O
Invasion	O
in	O
Prostate	O
Cancer	I:C0376358
Cells	O
by	O
Inhibiting	B:C0021469
PI3K	O
/	O
Akt	O
Signaling	O
Pathway	O
.	O

Tumor	B:C2975187
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	O
of	O
human	O
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	B:C2975187
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	O
of	O
human	O
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	B:C2975187
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	O
of	O
human	O
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	B:C1269955
and	O
metastasis	O
of	O
human	O
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	B:C0027627
of	O
human	O
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	O
of	O
human	B:C0086418
tumors	O
.	O

Tumor	O
necrosis	I:C2975187
factor	I:C2975187
-α	I:C2975187
(	I:C2975187
TNF	I:C2975187
-α	I:C2975187
)	I:C2975187
-	I:C2975187
induced	I:C2975187
protein	I:C2975187
8	I:C2975187
-	I:C2975187
like	I:C2975187
2	I:C2975187
(	O
TNFAIP8L2	O
,	O
TIPE2	O
)	O
is	O
involved	O
in	O
the	O
invasion	O
and	O
metastasis	O
of	O
human	O
tumors	B:C0027651
.	O

However	O
,	O
the	O
functional	O
role	O
of	O
TIPE2	B:C2975187
in	O
prostate	O
cancer	I:C0376358
remains	O
unclear	O
.	O

However	O
,	O
the	O
functional	O
role	O
of	O
TIPE2	O
in	O
prostate	B:C0376358
cancer	I:C0376358
remains	O
unclear	O
.	O

In	O
the	O
present	O
study	B:C2603343
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	B:C2975187
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	B:C0376358
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	B:C1947901
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	B:C3537153
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	B:C2975187
-	O
mediated	O
oncogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
TIPE2	O
in	O
prostate	O
cancer	I:C0376358
and	O
cancer	O
progression	I:C1947901
including	O
the	O
molecular	O
mechanism	I:C3537153
that	O
drives	O
TIPE2	O
-	O
mediated	O
oncogenesis	B:C0007621
.	O

Our	O
results	B:C0456984
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	O
in	O
human	O
prostate	O
cancer	I:C0376358
tissues	O
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	B:C2975187
was	O
lowly	O
expressed	O
in	O
human	O
prostate	O
cancer	I:C0376358
tissues	O
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	B:C1171362
in	O
human	O
prostate	O
cancer	I:C0376358
tissues	O
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	O
in	O
human	B:C0086418
prostate	O
cancer	I:C0376358
tissues	O
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	O
in	O
human	O
prostate	B:C0376358
cancer	I:C0376358
tissues	O
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	O
in	O
human	O
prostate	O
cancer	I:C0376358
tissues	B:C0040300
and	O
cell	O
lines	I:C0085983
.	O

Our	O
results	O
showed	O
that	O
TIPE2	O
was	O
lowly	O
expressed	O
in	O
human	O
prostate	O
cancer	I:C0376358
tissues	O
and	O
cell	B:C0085983
lines	I:C0085983
.	O

In	O
addition	O
,	O
restored	O
TIPE2	B:C2975187
obviously	O
inhibits	O
proliferation	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

In	O
addition	O
,	O
restored	O
TIPE2	O
obviously	O
inhibits	B:C0021469
proliferation	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

In	O
addition	O
,	O
restored	O
TIPE2	O
obviously	O
inhibits	O
proliferation	O
in	O
prostate	B:C0376358
cancer	I:C0376358
cells	O
.	O

In	O
addition	O
,	O
restored	O
TIPE2	O
obviously	O
inhibits	O
proliferation	O
in	O
prostate	O
cancer	I:C0376358
cells	B:C0334227
.	O

TIPE2	B:C2975187
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	B:C1514559
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	B:C1533574
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	B:C1269955
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	B:C0376358
cancer	I:C0376358
cells	O
.	O

TIPE2	O
overexpression	O
also	O
suppresses	O
the	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
process	O
and	O
migration	O
/	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	B:C0334227
.	O

Mechanistically	O
,	O
TIPE2	B:C2975187
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	B:C1514559
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	B:C0021469
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	B:C0031715
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	B:C2936824
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	B:C2936824
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	B:C0164786
in	O
prostate	O
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	B:C0376358
cancer	I:C0376358
cells	O
.	O

Mechanistically	O
,	O
TIPE2	O
overexpression	O
obviously	O
inhibits	O
the	O
phosphorylation	O
levels	O
of	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
(	O
phosphatidylinositol	O
3	I:C2936824
-	I:C2936824
kinase	I:C2936824
)	O
and	O
Akt	O
in	O
prostate	O
cancer	I:C0376358
cells	B:C0334227
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	B:C2975187
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	B:C1514559
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	B:C1533574
,	O
and	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	B:C1269955
in	O
prostate	O
cancer	I:C0376358
cells	O
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
in	O
prostate	B:C0376358
cancer	I:C0376358
cells	O
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	B:C0334227
by	O
inhibiting	O
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

In	O
conclusion	O
,	O
for	O
the	O
first	O
time	O
we	O
demonstrated	O
that	O
TIPE2	O
overexpression	O
may	O
suppress	O
proliferation	O
,	O
migration	O
,	O
and	O
invasion	O
in	O
prostate	O
cancer	I:C0376358
cells	O
by	O
inhibiting	B:C0021469
the	O
PI3K	O
/	O
Akt	O
signaling	O
pathway	O
.	O

Therefore	O
,	O
TIPE2	B:C2975187
might	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
human	O
prostate	O
cancer	I:C0376358
.	O

Therefore	O
,	O
TIPE2	O
might	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	B:C1513403
for	O
human	O
prostate	O
cancer	I:C0376358
.	O

Therefore	O
,	O
TIPE2	O
might	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
human	B:C0086418
prostate	O
cancer	I:C0376358
.	O

Therefore	O
,	O
TIPE2	O
might	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
human	O
prostate	B:C0376358
cancer	I:C0376358
.	O

